<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ijcs</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Cardiovascular Sciences</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Int. J. Cardiovasc. Sci.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2359-4802</issn>
      <issn pub-type="epub">2359-5647</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">gNK33trb844FJ9J9FTkGBmN</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S2359-56472020000200131</article-id>
      <article-id pub-id-type="publisher-id">ijcs.20200008</article-id>
      <article-id pub-id-type="doi">10.36660/ijcs.20200008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>EDITORIAL</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Factors Associated With Quality of Life in Patients with Systemic Arterial Hypertension</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-3105-9019</contrib-id>
          <name>
            <surname>Nogueira</surname>
            <given-names>Armando da Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state">RJ</named-content>
        </addr-line>
        <country country="BR">Brazil</country>
        <institution content-type="original"> Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ &#8211; Brazil </institution>
      </aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Armando da Rocha Nogueir</bold> Universidade Federal do Rio de Janeiro - Cl&#237;nica M&#233;dica - Rua Visconde de Silva, 52-602, Postal Code: 22271-092, Rio de Janeiro, RJ &#8211; Brazil. E-mail: <email>armando.nogueira@terra.com.br</email> </corresp>
      </author-notes>
      <pub-date publication-format="electronic" date-type="pub">
        <day>09</day>
        <month>03</month>
        <year>2020</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <season>Mar-Apr</season>
        <year>2020</year>
      </pub-date>
      <volume>33</volume>
      <issue>02</issue>
      <fpage>131</fpage>
      <lpage>132</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <kwd>Blood Pressure, Cardiovascular Diseases/prevention and control</kwd>
        <kwd>Antihypertensive Agents/therapeutic use</kwd>
        <kwd>Hypertension/ therapy</kwd>
        <kwd>Exercise</kwd>
        <kwd>Quality of Life</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>In 1966, Avedis Donabedian published a seminal article <sup><xref ref-type="bibr" rid="B1">1</xref></sup> showing the importance of measuring health care quality. Donabedian also defined that it should be done in the dimensions of structure, process or results. <sup><xref ref-type="bibr" rid="B2">2</xref></sup> The author showed that the &#8220;results&#8221; dimension is not necessarily related to the other two. While the measurement of some results, such as mortality, is easy to be carried out, other results are difficult to be measured, such as quality of life and patients&#8217; satisfaction.</p>
    <p>In the early 80&#8217;s, I became interested in the subject of health care quality. My thesis to obtain the master&#8217;s degree in Internal Medicine from the Federal University of Rio de Janeiro Medical School was entitled &#8220;Hypertension: health care quality at the HU-UFRJ&#8221;.</p>
    <p>Therefore, it was a pleasant surprise when I was invited to write an editorial of an article about quality of life of patients with systemic arterial hypertension on this issue of International Journal of Cardiovascular Sciences.</p>
    <p>Based on the hypothesis that &#8220;physical conditioning is the main component of quality of life of hypertensive subjects&#8221;, in a cross-sectional study, the authors evaluated the effects of isometric handgrip training on blood pressure of hypertensive individuals to assess the factors associated with the quality of life of these patients.</p>
    <p>For this purpose, the authors used the SF-36 questionnaire, developed by the Rand Corporation, <sup><xref ref-type="bibr" rid="B4">4</xref></sup> which is a generic measure of quality life that has been translated and validated in Portuguese. <sup><xref ref-type="bibr" rid="B5">5</xref></sup> The instrument allows the determination of descriptive information and comparisons of populations, and assessment of health perception and quality of life of patients over time.</p>
    <p>This is then the first limitation of the study to be discussed. The authors did not present the calculation of the sample size required to describe the characteristics of the study population with respect to the eight domains of the questionnaire. In addition, according to the abstract of the study, 45 hypertensive patients participated in the study, but Table 1 in the article: &#8220;Factors Associated with Quality of Life in Patients with Systemic Arterial Hypertension&#8221;3 (colocar sobrescrito) describes 80 participants (n = 80).</p>
    <p>Participants that met the eligibility criteria, which were probably developed for the intervention study, were hypertensive, and overweight or obese (probably mostly obese class I, since the mean BMI was 30.7 kg/m <sup>2</sup> ). Obesity is associated with hypertension, and to analyze the effect of each condition using the quality of life questionnaire, the authors should have performed a multiple-variable analysis, which, in turn, would be impossible considering the relatively small sample size. The lack of a multiple-variable analysis also hinders the assessment of the effect of medication use on patients&#8217; quality of life, <sup><xref ref-type="bibr" rid="B6">6</xref></sup> especially knowing that the more severe the disease, the more drugs (and at higher doses) a patient receives. <sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
    <p>Analysis of the statistically significant variables showed known and expected data, such as: the positive relationships between functional capacity and higher education level, and functional capacity and muscle strength, and a negative relationship between functional capacity and higher BMI. However, how are these data related to hypertension?</p>
    <p>The only result related with arterial hypertension does not make sense &#8211; the positive relationship between physical aspects and systolic blood pressure &#8211; which may have resulted from contamination by any other variable. This result deserves criticism, as it may lead the readers to understand that an elevated systolic blood pressure is beneficial, while it has already been shown that an intensive blood pressure control improves patients&#8217; survival and quality of life. In fact, with the recent publications by the Sprint Research Group <sup><xref ref-type="bibr" rid="B8">8</xref></sup> and the Sprint Mind Investigators, <sup><xref ref-type="bibr" rid="B9">9</xref></sup> the control of blood pressure to lower levels became a target in all guidelines.</p>
    <p>Despite these problems in this study, I congratulate the authors for the decision to walk this important and hard path of study. A good quality of life guarantees treatment compliance of chronic diseases and must be investigated in hypertension.</p>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Donabedian A. The quality of medical care. The Milbank Quartely. 2005;83($):691-729.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donabedian</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The quality of medical care</article-title>
          <source>The Milbank Quartely</source>
          <year>2005</year>
          <volume>83</volume>
          <issue>$</issue>
          <fpage>691</fpage>
          <lpage>729</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Donabedian A. Criteria and Standards for quality assessments and monitoring. QRB. Qual Rev Bull. 1986;12(3) 99-108.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donabedian</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Criteria and Standards for quality assessments and monitoring</article-title>
          <source>QRB. Qual Rev Bull</source>
          <year>1986</year>
          <volume>12</volume>
          <issue>3</issue>
          <fpage>99</fpage>
          <lpage>108</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Silva GO, Andrade-Lima A, Germano-Soares AH, Lima Jr D, Rodrigues SLC, Ritti-Dias R, et al. Int J Cardiovasc Sci. 2019; [online] ahead print. PP.0-0.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>GO</given-names>
            </name>
            <name>
              <surname>Andrade-Lima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Germano-Soares</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>D</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>SLC</given-names>
            </name>
            <name>
              <surname>Ritti-Dias</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <source>Int J Cardiovasc Sci</source>
          <year>2019</year>
          <comment>online</comment>
          <comment>ahead print</comment>
          <comment>PP.0-0</comment>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Kimmel PL. Just whose quality of life isit anyway? Controversies and consistencies in measurements of quality of life. Kidney Int. 2000; 57(Suppl 74):S113-S120.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimmel</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Just whose quality of life isit anyway? Controversies and consistencies in measurements of quality of life</article-title>
          <source>Kidney Int</source>
          <year>2000</year>
          <volume>57</volume>
          <supplement>Suppl 74</supplement>
          <fpage>S113</fpage>
          <lpage>S120</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Ciconelli RM, Ferraz MB, Santos W, Mein&#227;o I, Quaresma MR. Tradu&#231;&#227;o para a l&#237;ngua portuguesa e valida&#231;&#227;o do question&#225;rio gen&#233;rico de avalia&#231;&#227;o de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999; 39(3): 143-50.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciconelli</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ferraz</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Mein&#227;o</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Quaresma</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Tradu&#231;&#227;o para a l&#237;ngua portuguesa e valida&#231;&#227;o do question&#225;rio gen&#233;rico de avalia&#231;&#227;o de qualidade de vida SF-36 (Brasil SF-36)</article-title>
          <source>Rev Bras Reumatol</source>
          <year>1999</year>
          <volume>39</volume>
          <issue>3</issue>
          <fpage>143</fpage>
          <lpage>150</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Guyatt GH. Measuring health-related quality of life: General issues. Can Respir J. 1997; 4(3):123-30.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guyatt</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>Measuring health-related quality of life: General issues</article-title>
          <source>Can Respir J</source>
          <year>1997</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>123</fpage>
          <lpage>130</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986; 314(26): 1656-64.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Croog</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Testa</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bulpitt</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>CD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The effects of antihypertensive therapy on the quality of life</article-title>
          <source>N Engl J Med</source>
          <year>1986</year>
          <volume>314</volume>
          <issue>26</issue>
          <fpage>1656</fpage>
          <lpage>1664</lpage>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. The Sprint Research Group. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco DM, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373(22): 2103-16.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>The Sprint Research Group</collab>
            <name>
              <surname>Wright</surname>
              <given-names>JT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Whelton</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Sink</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Rocco</surname>
              <given-names>DM</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A randomized trial of intensive versus standard blood-pressure control</article-title>
          <source>N Engl J Med</source>
          <year>2015</year>
          <volume>373</volume>
          <issue>22</issue>
          <fpage>2103</fpage>
          <lpage>2116</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. The Sprint Mind Investigators. Williamson JD, Pajews Ki NM, Auchus AP, Bryan RN, Chelune G, et al. Effect of intensive vs standard blood pressure control on probabel dementia. JAMA. 2019; 321(6): 553-61.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>The Sprint Mind Investigators</collab>
            <name>
              <surname>Williamson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Pajews Ki</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Auchus</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Bryan</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Chelune</surname>
              <given-names>G</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Effect of intensive vs standard blood pressure control on probabel dementia</article-title>
          <source>JAMA</source>
          <year>2019</year>
          <volume>321</volume>
          <issue>6</issue>
          <fpage>553</fpage>
          <lpage>561</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
